The product is a layered risk assessment tool that has been designed to enable business travel within a pandemic, and to provide instant assessments of the medical and logistical risks posed by every unique proposed travel itinerary.
Healix International Chief Medical Officer Dr Adrian Hyzler explained: “We know that in this incredibly challenging time, all businesses need to be supported in resuming operations and providing an increased duty of care to their travellers. This tool allows any organisation to have the confidence to deploy employees safely and with the knowledge that those travelling do not pose a high medical risk of severe disease.”
Mike Webb, CEO of Healix International, added: “Businesses cannot operate via virtual conference tools forever; business-critical travel needs to resume, and for many, that needs to happen now. However, employee expectations and legislation have drastically changed in the wake of Covid-19 and organisations across every industry are faced with the difficulty of demonstrating their duty of care obligations to their employees in an incredibly complex operating environment, particularly when it comes to weighing up the risks of international travel.
“Covid-19 has turned the entire concept of travel risk on its head. For the first time in a generation, risk is highest in parts of the world that have historically been considered the safest, and these countries account for more than 90 per cent of global business travel. Logistical and operational restrictions across the world are changing by the day. And information related to Covid-19 and necessary measures to reduce transmission remains vast, ambiguous, highly complex and often incomplete. Even the most well-resourced organisations are struggling to stay on top of the magnitude of information that is published each day.”